Under normal conditions, the adrenal glucocorticoids, the endproduct of the hypothalamic-pituitaryadrenal (HPA) axis, provide a frontline of defence against threats to homeostasis (i.e. stress). On the other hand, chronic HPA drive and glucocorticoid hypersecretion have been implicated in the pathogenesis of several forms of systemic, neurodegenerative and affective disorders. The HPA axis is subject to gonadal influence, indicated by sex differences in basal and stress HPA function and neuropathologies associated with HPA dysfunction. Functional cross-talk between the gonadal and adrenal axes is due in large part to the interactive effects of sex steroids and glucocorticoids, explaining perhaps why several disease states linked to stress are sex-dependent. Realizing the interactive nature by which the hypothalamic-pituitary-gonadal and HPA systems operate, however, has made it difficult to model how these hormones act in the brain. Manipulation of one endocrine system is not without effects on the other. Simultaneous manipulation and assessment of both endocrine systems can overcome this problem. This dual approach in the male rat reveals that testosterone can act and interact on different aspects of basal and stress HPA function. Basal adrenocorticotropic hormone (ACTH) release is regulated by testosterone-dependent effects on arginine vasopressin synthesis, and corticosterone-dependent effects on corticotropin-releasing hormone (CRH) synthesis in the paraventricular nucleus (PVN) of the hypothalamus. In contrast, testosterone and corticosterone interact on stress-induced ACTH release and drive to the PVN motor neurones. Candidate structures mediating this interaction include several testosterone-sensitive afferents to the HPA axis, including the medial preoptic area, central and medial amygdala and bed nuclei of the stria terminalis. All of these relay homeostatic information and integrate reproductive and social behaviour. Because these modalities are affected by stress in humans, a dual systems approach holds great promise in establishing further links between the neuroendocrinology of stress and the central bases of sex-dependent disorders, including psychiatric, cardiovascular and metabolic disease.
Studies of gonadal and adrenal interactions have generally focused on the mechanisms by which stress disrupts reproduction. The relationship between these two endocrine systems, however, is by no means unidirectional. Thus, variations in the magnitude of stress-related HPA activity in males and females are explainable as a function of sex steroid levels. Remarkably, despite the potency by which sex steroids regulate glucocorticoid release and genuine sex differences in HPA function and neuropathology associated with HPA dysfunction (1, 2) , how sex steroids operate within the central nervous system to regulate the HPA axis remains unresolved. While the central pathways regulating HPA output have been extensively studied, the manner by which these pathways are regulated by sex steroids is not well specified. This review sheds light on the depth to which the hypothalamic-pituitarygonadal (HPG) and HPA axes interact and on the inhibitory nature by which testosterone regulates stress-related HPA function, describing how central features of this regulation can be unmasked using a dual endocrine approach.
To begin to understand how testosterone can act and interact with glucocorticoids on HPA function, a basic introduction to the axis is provided here. The HPA axis begins at the level of the paraventricular nucleus (PVN) of the hypothalamus. More specifically, afferents conveying stress-and homeostatic-related information in the brain ultimately converge on the medial parvocellular neurones of the PVN. Several additional cell types are housed within the PVN, including the dorsal-and medioventral-parvocellular (dp and mpv), and posterior magnocellular neurones (PM), subserving autonomic and posterior pituitary function, respectively (3) . The medial parvocellular neurones of the PVN represent the neuroendocrine arm of the HPA axis, comprising the final common pathway through which the brain drives the anterior pituitary corticotropes to synthesize and release adrenocorticotropic hormone (ACTH). ACTH, in turn, stimulates the synthesis and release of adrenal glucocorticoids, corticosterone in the rat and cortisol in humans and nonhuman primates.
In response to stress, or during the circadian peak in basal HPA activity, the medial parvocellular neurones of the PVN release several peptides into the pituitary portal circulation that stimulate both the de novo synthesis and release of ACTH. Foremost among these peptides are corticotropinreleasing hormone (CRH) and arginine vasopressin (AVP). In the rat, CRH dominates over pituitary ACTH synthesis and release. AVP by itself is a weak secretogog, but potentiates the stimulatory effects of CRH on ACTH secretion (4). CRH-producing medial parvocellular neurones coexpress AVP, although the amount synthesized is relatively low under basal conditions. AVP synthesis in these neurones is increased in response to chronic stress and by the removal of glucocorticoid negative feedback in adrenalectomized (ADX) rats (5). Thus, sustained ACTH release during acute stress, or an elevated ACTH response during chronic stress, is thought to be mediated by the potentiating effects of AVP on ACTH release, otherwise inhibited by the negative-feedback actions of elevated plasma glucocorticoid concentrations. Explored in greater detail below, the sensitivity of parvocellular CRH and AVP to glucocorticoid negative feedback and ADX proved instrumental in discriminating between the central independent and glucocorticoid interactive actions of testosterone on HPA function.
Reciprocal interactions between the HPG and HPA axes
The most obvious example of how the adrenal axis regulates gonadal function is seen by the inhibitory effects of stress on reproductive behaviour and various components of the HPG axis, including sex steroid release. The mechanisms by which this occurs will not be discussed here (6, 7) . What requires emphasis is that several components of the gonadal axis which are altered by stress and glucocorticoids exert reciprocal effects on the HPA axis (8) . In the rodent, central administration of CRH inhibits the synthesis of luteinizing hormone-releasing hormone (LHRH) and plasma luteinizing hormone (LH), consistent with the direct contact of CRHimmunoreactive neurones with LHRH-expressing neurones in the medial preoptic area (MPOA) of the hypothalamus. Interestingly, central LHRH administration stimulates plasma cortisol levels in the ewe (9) . Whether this reflects the existence of functionally reciprocal LHRH-parvocellular contacts in the PVN of the rat is intriguing, made more so by the fact that not all LHRH-expressing neurones in the rat brain are median eminence-pituitary projecting (10, 11) .
Reciprocal interactions are most clearly apparent between the steroid endproducts of the gonadal and adrenal axes. In humans, rats and nonrodent mammals, stress and high doses of glucocorticoids generally disrupt all aspects of HPG function, including reproductive behaviour, LHRH expression, plasma LH secretion and sex steroid synthesis and release (6, 7) . Conversely, oestrogens and androgens, which form the basis for sex and individual differences in HPA function, act on several levels of the HPA axis, including adrenocorticoid synthesis, stress-induced ACTH and glucocorticoid release and CRH and AVP synthesis in the PVN (8) .
In addition to regulating the feedforward elements of the HPA axis, several in-vivo studies in the rat indicate sex differences and implicate sex steroid effects on glucocorticoidmediated negative-feedback potency (12) . This would suggest a potential for gonadal and adrenal interactions at the genomic and cellular levels. Indeed, glucocorticoid, progesterone and androgen receptors can recognize and function at a common DNA site (13) . Moreover, androgen and glucocorticoid receptors are capable of physically interacting to regulate transcription (14) . If gonadal and adrenal steroids interact in this manner on HPA function, this would suggest a multitude of brain regions showing both sex and adrenal steroid receptors and functional connectivity to the HPA axis. Possible candidates, in this case, would include the hippocampus, amygdala, the brain stem and several hypothalamic nuclei (15-18, 19, 20) .
Testosterone and HPA function
This section will focus on the hormonal and hypothalamic effects of testosterone on HPA function, reinforcing the importance of a dual endocrine approach to sex steroid action and interactions in the brain. Sex differences in basal and stress-induced HPA activity are apparent in a variety of species, in which males typically show lower ACTH and glucocorticoid levels under both conditions (21, 22) . This sex difference in HPA function is attributed, in part, to inhibitory effects of testosterone in males. ACTH and corticosterone responses to acute stress in the male rat are increased by gonadectomy (GDX), and this effect is reversed with testosterone replacement or 5a-dihydrotestosterone (5a-DHT), the reduced nonaromatizable form of testosterone (23, 24) . This suggests that the inhibitory effect of testosterone in males on stress HPA function is mediated by an androgen receptor-mediated effect, at least under acute stress conditions. It is important to note that in many tissues, including the brain, testosterone can be metabolized to different and Testosterone and corticosterone interact on HPA function 507 biologically active forms, including its aromatization to oestrogen and reduction to 5a-DHT (25) . In the male, both oestrogen receptor isoforms, androgen receptors, as well as aromatase and 5a-reductase, exist in several brain nuclei (26) (27) (28) (29) . The extent to which all of these are contained specifically within PVN-projecting neurones (and their extended circuitries) and modulated by chronic stress has not been addressed.
Testosterone secretion in males fluctuates over the course of development and ageing in humans and rats (30) (31) (32) , and during the establishment of social status in the male rat (33) . These periods are also marked by extreme variations in basal and stress HPA function (33) (34) (35) . Thus, one question that comes to mind is the extent to which naturally occurring variations in plasma testosterone levels contribute to individual differences in the magnitude of HPA responses to stress. Our initial entry into this question indicated that under basal conditions plasma testosterone levels differ considerably amongst male rats with testis (gonadal-intact). As a group, intact male rats show reduced ACTH responses to acute restraint exposure compared to GDX rats, but with far greater variance ( Fig. 1 ) (23) . In GDX rats treated with testosterone within the physiological range seen in gonadal-intact males, the ACTH response to restraint varied strongly and negatively with basal testosterone levels. Thus, variations in the magnitude of the ACTH response to stress amongst gonadal-intact males appear to vary as a function of individual testosterone levels, and in a dose-related inhibitory manner.
Part of these findings may form the basis for what is commonly seen in dominance hierarchies. In numerous species, HPA activity varies inversely as a function of social status in which subordinates show increased glucocorticoid levels under stress conditions and /or decreased plasma testosterone levels, and the opposite occurs in dominants (36) (37) (38) . While variations in testosterone levels among groups of rats are often thought to reflect effects of social stress imposed on gonadal function, given the interactive potential of these systems, sex steroids probably play an active and enduring role in the formation of dominance hierarchies (39) . In a separate vein, the dose-dependent and reciprocal cross talk between the gonadal and adrenal systems, likely serves a common and adaptive function. For example, keeping in mind that both of these systems intersect at the metabolic level, Gomez and Dallman have shown that pubertal male rats are best capable of sustaining the metabolic demands of cold-stress if normal declines in circulating testosterone are allowed to occur (40) , perhaps permitting a more robust HPA response.
Anterior pituitary corticotrope (ACTH-producing) cells in the rat do not express androgen receptors and exhibit only minimal aromatase activity (41) . Compared to males, female rats show higher bioassayable levels of CRH, and higher CRH mRNA levels within medial parvocellular PVN neurones (42) . These findings suggest that sex steroid regulation of ACTH release is mediated above the level of the anterior pituitary and that sex steroids can operate, at the very least, on parvocellular function in the PVN. Using CRH and AVP peptide content as an indicator of preterminal storage levels in the rat median eminence, we found that the inhibitory effect of testosterone on stress-induced ACTH was strongly paralleled by resting-state changes in AVP, but not CRH content in the median eminence (23) . In the male rat, both isoforms of the oestrogen receptor and the androgen receptor are present within the PVN. These receptors do not appear to be expressed by endocrine-related (ACTH-regulating) CRHimmunoreactive (ir) neurones, but rather a clear majority are expressed by autonomic-related CRH-ir neurones of the PVN (17, 18, 26, 27, 43) . Thus, while testosterone regulation of stress-induced ACTH release can be explained by the inhibition of AVP biosynthesis, sex steroid regulation of the neuroendocrine arm of the HPA axis cannot occur directly at level of the PVN.
In addition to mediating a myriad of physiological effects, the adrenal glucocorticoids also exert negative-feedback effects on basal and stress-HPA activity. In humans and rats, males and females show marked differences in the degree to which exogenous glucocorticoids suppress basal and stressinduced ACTH secretion (12, 22, 44) . Thus, sex steroid effects on the magnitude of the ACTH response to stress could include actions on both the feedforward and feedback elements of the HPA axis. In the rat, attempts to relate sex differences and sex steroid effects on HPA responsiveness to stress on the basis of glucocorticoid receptor binding and expression within classical feedback sites (including the hippocampus, amygdala, hypothalamus, and pituitary) have been quite inconsistent (21, 45, 46) . Nonetheless, we extended our analysis of the effects of testosterone replacement on glucocorticoid receptor binding to include the MPOA because of the concentration of both glucocorticoid and androgen receptors in this region and their role in reproduction and social behaviour (23) . We found no dose-related effect of testosterone on mineralocorticoid or glucocorticoid receptor binding in the brain except for the MPOA. Glucocorticoid receptor binding showed a graded and positive response to testosterone replacement levels in GDX rats. Furthermore, either testosterone or corticosterone implants into the MPOA decreased plasma ACTH responses to restraint. This was paralleled by a decrease in resting-state levels of AVP, but not CRH, in the median eminence (Fig. 2) , similar to the effects of peripheral testosterone implants. Finally, bilateral lesions of the MPOA blocked the inhibition of stress-induced ACTH release that would normally occur in animals with elevated testosterone levels. Based on these findings: (i) it appears that the dose-related inhibitory effect of testosterone on stress HPA function is mediated under basal conditions. (ii) This is reflected in the strong association between the magnitude of the ACTH response to stress and basal stores of AVP in the median eminence. (iii) Graded and preferential actions of testosterone on hypophysial AVP (not CRH) occurs upstream from the PVN. (iv) This upstream effect is produced by a testosteronedependent alteration in glucocorticoid feedback efficacy mediated at the level of the MPOA.
Unraveling gonadal-adrenal interactions in the brain: a dual endocrine approach While these studies shed some light on the upstream, regulatory, and glucocorticoid-interactive potential by which testosterone regulates PVN function, several candidate structures in the brain, in addition, to the MPOA, likely mediate or relay these central testosterone effects. If this occurs via direct and/or indirect (secondary, glucocorticoiddependent) modes of action, how can we begin to unravel androgen from glucocorticoid stress-sensitive pathways in the brain? Given the intimacy through which the gonadal and adrenal axes interact, one major hurdle in addressing this question lies in the fact that manipulating one endocrine system always alters the output of the other. Stress, exogenous glucocorticoids and ADX decrease plasma testosterone levels in male rats. In addition to altering stress HPA activity, GDX also disrupts the normal daily rhythm in circulating glucocorticoids. We should not assume therefore that glucocorticoid feedback inhibition of the HPA occurs independently of the gonadal axis. Conversely, to what extent does testosterone regulation of the HPA axis occur independently of glucocorticoids?
We have recently examined this problem by employing a 3r3 group design encompassing sham endocrinectomy (GDX/ADX) and endocrinectomy with or without steroid replacement (GDXttestosterone/ADXtcorticosterone). This design permitted simultaneous assessment of the potential independent and interactive effects of testosterone and corticosterone on basal and stress HPA function (Fig. 3 ) (47) . Under basal conditions, HPA activity is regulated by corticosterone-dependent effects on CRH, and testosteronedependent effects on AVP biosynthesis in the PVN. Thus, GDX male rats show normal increases in parvocellular CRH, but not AVP mRNA in response to ADX. Testosterone replacement restored AVP mRNA in ADX rats. Under stress conditions, in contrast, HPA function is determined by gonadal-adrenal interactions occurring above the level of the PVN. Thus, while plasma ACTH responses to restraint exposure are strongly inhibited by corticosterone in gonadalintact rats, this glucocorticoid inhibitory effect is abolished by GDX and reinstated with testosterone replacement (Fig. 4,  top) . This was paralleled by similar responses in the number of medial parvocellular neurones recruited to induce Fos protein (Fig. 4, bottom) . In other words, similar to effects on stress-induced ACTH, corticosterone effectively inhibited the number of medial parvocellular neurones activated by stress, but only in animals with testosterone. To summarize, under basal conditions, CRH and AVP synthesis appear to be regulated by independent steroid effects, whereas stressinduced drive to the PVN is regulated by a corticosterone and testosterone interaction. Refining our earlier hypothesis, it now seems reasonable to propose that gonadal influences on stress HPA function are determined by the degree to which testosterone and corticosterone interact on neurogenic drive to the PVN motorneurones, in addition to effects on AVP and CRH synthesis. An interesting example of this is seen in models of social stress in the male rat. Compared to socially dominant male rats, subordinate males show decreased basal plasma testosterone levels, and increased AVP-ir, but not CRH-ir within the external (anterior pituitary regulating) zone of the median eminence (48) . Following acute exposure to a dominant male rat in a novel environment, subordinates hypersecrete ACTH, correlated with a selective depletion of AVP from the median eminence (49) . These responses in the subordinate rat are not seen, however, when the social encounter occurs in an environment familiar to the subordinate (49) . Thus, despite the chronic decrease in plasma testosterone and increase in hypophysial AVP associated with subordinate status, elevated ACTH responses to stress are not always indicated. Taken together with our findings, the magnitude of the ACTH response to stress appears to be regulated, in larger part, by the extent to which pathways mediating stress-induced drive to the PVN are sensitive to individual differences in plasma testosterone (and/or corticosterone) levels.
Studies employing stress-induced measures of Fos activation remain in keeping with the idea that sex steroids can operate on stress-induced drive to the PVN motorneurones. In contrast to the stimulatory effects of high oestrogen levels on stress-induced HPA activity in female rats (50) , ACTH responses to auditory stress are attenuated with low oestrogen replacement (51) . This is accompanied by decrements in the number of Fos-responding medial parvocellular neurones in the PVN, and in the central nucleus of the amygdala and medullary catecholaminergic cell groups. Similarly, androgen effects on HPA responses to stress in the male rat, in some cases, are also paralleled by changes in stress-induced Fos expression in the brain. Thus, GDX male rats show androgenreversible increases in plasma ACTH and c-fos mRNA responses to novelty in the PVN and in the hippocampus (21, 52) . However, GDX does not alter plasma corticosterone and Fos responses to supine-immobilization stress within medial parvocellular neurones, nor within several androgen receptor-rich nuclei, including the medial amygdala, bed nuclei of the stria terminalis (BNST), locus coeruleus and lateral septum (53) . Thus, the sites at which testosterone acts Corticosterone replacement reversed the stimulatory effects of ADX on both stress-induced plasma ACTH and PVN Fos-immunoreactivity (ir) in rats with testis (Intact) and gonadectomized (GDX) rats replaced with testosterone (GDX+T), but not in GDX rats. This parallel response suggests that corticosterone and testosterone do not act independently on stress-induced ACTH release, but interact on stress-induced drive to the PVN motorneurones. Modified with permission (47). **P <0.01 versus ADX.
in the brain to regulate PVN-projecting pathways are likely stress-specific and therefore mediated by different circuits.
To begin sorting out where androgens act in the brain to regulate HPA function (see Fig. 5 ), we recently modified and extended one limb of our earlier design with respect to the glucocorticoid-independent effects of testosterone (Fig. 3 , middle column) (54) . The anterior and posterior portions of the BNST contain CRH-and AVP-projecting cells to the PVN (55, 56) , and make bidirectional contacts between the amygdala and cells occupying the medial parvocellular zone of the PVN (57) (58) (59) (60) , forming a functional and, perhaps, testosterone-sensitive bridge between the amygdala and PVN. Moreover, several studies also point to an inhibitory role for hypothalamic AVP on basal and stress HPA activity (23, 61) . Thus, we focused on the extent to which GDX and androgen replacement could regulate CRH and AVP mRNA in the BNST and amygdala, in the absence of circulating corticosterone using ADX male rats (54) . This design revealed glucocorticoid-independent, stimulatory effects of testosterone on CRH and AVP mRNA expression within the anterior fusiform and posterior BNST, respectively, and on AVP expression within the medial amygdala. In contrast, CRH mRNA expression levels in the central amygdala were inhibited by testosterone in adrenal-intact, but not in ADX rats. These effects on peptide expression in the amygdala and BNST were paralleled by testosterone-dependent alterations in AVP, but not CRH mRNA in the medial parvocellular PVN.
Elegant functional lesion studies in the rat by Herman and colleagues indicate that the anterior (CRH-producing) and posterior (AVP-producing) regions of the BNST can, in turn, exert an inhibitory and perhaps selective influence on CRH and AVP mRNA expression, respectively, in the PVN (62) . Taken together with our findings, this would suggest that the selective effects of testosterone on medial parvocellular AVP may be mediated at the level of the amygdala, relayed via stimulatory CRH-and inhibitory AVP-expressing neurones of the BNST. Inhibitory GABAergic neurones of the MPOA could also gain access to this circuit given their reciprocal connections with the BNST and medial amygdala, and stimulation by testosterone (63) (64) (65) . The MPOA probably acts as an important and obligatory relay in this regard, as bilateral lesions of the MPOA prevent high peripheral testosterone levels from inhibiting stress-induced ACTH (23) .
Conclusions
Portions of this circuitry in the rat overlap with a network of systems in the brain processing metabolic and gustatory information, and mediating social and reproductive behaviour. Because all of these modalities are debilitated by stress and in depression in humans, how and where testosterone and stress pathways intersect in the brain remains an important question. While this represents a large and complex task, a dual systems approach provides a testable and logical framework with which to map, model and phenotype where in the rat brain sex steroids act and interact on stress-responding pathways in the brain.
Individuals afflicted with depression show varying degrees of resistance to antidepressant treatment. Valid attempts are being made to relate this heterogeneity to individual differences in cortisol release patterns and HPA hyperactivity (66) . This heterogeneity may very well depend on the gonadal axis, given the potency by which sex steroids act on the adrenal axis, the instability of testosterone levels in males, and how this variability in testosterone accounts for individual differences in HPA responses to stress. Recognizing this, emerging clinical studies now show that a subset of depressed males are hypogonadal and that androgen replacement can reduce depressive symptomology (67) . Thus, simultaneous assessment of gonadal and adrenal activity in depressed patients bears great therapeutic as well as a diagnostic potential. . Direct projections from the medial and central cell groups of the amygdala to the adrenocorticotropic hormone-regulating portion of the PVN are few and limited to the periventricular and autonomic-related cell groups. However, corticotropin-releasing hormone (CRH)-and AVPcontaining neurones of the anterior and posterior aspects of the bed nuclei of the stria terminalis (BNST), respectively, should prove to be critical components in this design, considering their direct communication with the PVN, sensitivity to androgens, and connectivity with several forebrain regulators of the HPA axis, including the amygdala, medial preoptic area, as well as converging limbic (septum, ventral subiculum) input. Androgen receptors are expressed in most, if not all of these structures. MeA, medial amygdala; CeA, central amygdala; al, anterolateral; av, anteroventral; ov, oval; fu, fusiform; posterior subdivision of the BNST encompasses AVPexpressing neurones; PVN of the hypothalamus including the medial parvocellular (mp) and periventricular (pv) neuroendocrine components, and the autonomic-related dorsal parvocellular (dp), lateral posterior (lp) and medioventral parvocellular (mpv) subdivisions; limbic=septum and ventral subiculum of the hippocampus. Modified with permission (55) (56) (57) (58) (59) (60) (61) 68) . For a discussion, see (54) .
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